<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0007" orientation="portrait" position="float">
 <label>Table 7.</label>
 <caption>
  <p>
   <italic>In silico</italic> predictions of the pharmacokinetics properties for spirooxindole 
   <bold>6a</bold>.
  </p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
  </colgroup>
  <thead>
   <tr>
    <th align="left">Cpd.</th>
    <th align="center">GIA</th>
    <th align="center">BBB</th>
    <th align="center">P-gp substrate</th>
    <th align="center">CYP1A2 inhibitor</th>
    <th align="center">CYP2C9 inhibitor</th>
    <th align="center">CYP2C19 inhibitor</th>
    <th align="center">CYP3A4 inhibitor</th>
    <th align="center">CYP2D6 inhibitor</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">
     <bold>6a</bold>
    </td>
    <td align="left">High</td>
    <td align="left">No</td>
    <td align="center">No</td>
    <td align="center">Yes</td>
    <td align="center">Yes</td>
    <td align="center">Yes</td>
    <td align="center">No</td>
    <td align="center">No</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="TF4">
   <p>
    <bold>GIA:</bold> gastrointestinal absorption; 
    <bold>BBB:</bold> blood-brain barrier permeation; 
    <bold>P-gp:</bold> permeability glycoprotein
    <bold>; CYP1A2, CYP2C9, CYP2C19, CYP3A4</bold> and 
    <bold>CYP2D6</bold> are the five major isoforms of cytochromes P450.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
